World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
75
Citations
22296
World Ranking
1490
National Ranking
651

Overview

Jane L. Burns is affiliated with the University of Washington in the United States. Their research focuses primarily within the field of Medicine, with significant contributions to subfields including Urology, Pulmonary and Respiratory Medicine, Epidemiology, Molecular Medicine, and Rheumatology.

The scientist's work covers a range of topics related to urinary and respiratory health. Key areas of research include:

  • Urinary Tract Infections Management
  • Urinary Bladder and Prostate Research
  • Cystic Fibrosis Research Advances
  • Urological Disorders and Treatments
  • Antibiotic Resistance in Bacteria
  • Pelvic floor disorders treatments
  • Bacterial biofilms and quorum sensing

Jane L. Burns has published research papers in various venues. Frequent publication venues include:

  • UNC Libraries
  • Journal of Hospital Infection
  • Continence
  • Proceedings of the Institution of Mechanical Engineers Part H Journal of Engineering in Medicine
  • ACS Omega

Recent papers authored or co-authored by Jane L. Burns include:

  • "Synergistic activity of weak organic acids against uropathogens," 2021, Journal of Hospital Infection
  • "Weak organic acid synergy towards the prevention of catheter blockages," 2021, Journal of Hospital Infection
  • "Comparing an Integrated Amphiphilic Surfactant to Traditional Hydrophilic Coatings for the Reduction of Catheter-Associated Urethral Microtrauma," 2024, ACS Omega

The scientist has collaborated frequently with several researchers, including:

  • Colin P. McCoy
  • David Pollard
  • Matthew P. Wylie
  • George Retsch-Bogart
  • Louise Carson

Best Publications

  • Pathophysiology and management of pulmonary infections in cystic fibrosis.

    Ronald L. Gibson;Jane L. Burns;Bonnie W. Ramsey

  • Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients.

    Eric E. Smith;Danielle G. Buckley;Zaining Wu;Channakhone Saenphimmachak

  • Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial.

    Lisa Saiman;Bruce C. Marshall;Bruce C. Marshall;Nicole Mayer-Hamblett;Jane L. Burns

  • Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis

    Lawrence R. Mulcahy;Jane L. Burns;Stephen Lory;Kim Lewis

  • Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis.

    Jane L. Burns;Ronald L. Gibson;Sharon McNamara;Darlene Yim

  • Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa.

    Robert K. Ernst;Eugene C. Yi;Lin Guo;Kheng B. Lim

  • Microbiology of Sputum from Patients at Cystic Fibrosis Centers in the United States

    Jane L. Burns;Julia Emerson;Jenny R. Stapp;Darlene L. Yim

  • Clinically Feasible Biofilm Susceptibility Assay for Isolates of Pseudomonas aeruginosa from Patients with Cystic Fibrosis

    Samuel M. Moskowitz;Jessica M. Foster;Julia Emerson;Jane L. Burns;Jane L. Burns

  • Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis.

    Margaret Rosenfeld;Ronald L. Gibson;Sharon McNamara;Julia Emerson

  • Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients.

    David A. D'Argenio;Manhong Wu;Lucas R. Hoffman;Hemantha D. Kulasekara

  • Susceptibility testing of Pseudomonas aeruginosa isolates and clinical response to parenteral antibiotic administration: lack of association in cystic fibrosis.

    Arnold L. Smith;Stanley B. Fiel;Nicole Mayer-Hamblett;Bonnie Ramsey

  • Effect of Chronic Intermittent Administration of Inhaled Tobramycin on Respiratory Microbial Flora in Patients with Cystic Fibrosis

    Jane L. Burns;Jill M. Van Dalfsen;Ribhi M. Shawar;Kelly L. Otto

  • Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis.

    Ronald L. Gibson;Julia Emerson;Sharon McNamara;Jane L. Burns

  • Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial.

    Lisa Saiman;Michael Anstead;Nicole Mayer-Hamblett;Larry C. Lands

  • Pseudomonas aeruginosa lasR mutants are associated with cystic fibrosis lung disease progression.

    Lucas R. Hoffman;Hemantha D. Kulasekara;Julia Emerson;Laura S. Houston

  • Association between Pulmonary Function and Sputum Biomarkers in Cystic Fibrosis

    Nicole Mayer-Hamblett;Moira L. Aitken;Frank J. Accurso;Richard A. Kronmal

  • Genetic Adaptation of Pseudomonas aeruginosa to the Airways of Cystic Fibrosis Patients Is Catalyzed by Hypermutation

    A. Mena;E. E. Smith;J. L. Burns;D. P. Speert

  • LasR Variant Cystic Fibrosis Isolates Reveal an Adaptable Quorum-Sensing Hierarchy in Pseudomonas aeruginosa

    John B Feltner;Daniel J. Wolter;Daniel J. Wolter;Christopher E. Pope;Marie-Christine Groleau

  • Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection

    J P Clancy;L Dupont;M W Konstan;J Billings

  • Neutrophil extracellular trap (NET)-mediated killing of Pseudomonas aeruginosa: evidence of acquired resistance within the CF airway, independent of CFTR.

    Robert L. Young;Kenneth C. Malcolm;Jennifer E. Kret;Silvia M. Caceres

  • Anaerobic killing of mucoid Pseudomonas aeruginosa by acidified nitrite derivatives under cystic fibrosis airway conditions

    Sang Sun Yoon;Ray Coakley;Gee W. Lau;Sergei V. Lymar

  • Whole-Genome Sequence Variation among Multiple Isolates of Pseudomonas aeruginosa

    David H. Spencer;Arnold Kas;Eric E. Smith;Christopher K. Raymond

Frequent Co-Authors

Bonnie W. Ramsey
Bonnie W. Ramsey University of Washington
Lucas R. Hoffman
Lucas R. Hoffman University of Washington
Lisa Saiman
Lisa Saiman Columbia University
Samuel I. Miller
Samuel I. Miller University of Washington
Margaret Rosenfeld
Margaret Rosenfeld University of Washington
Arnold L. Smith
Arnold L. Smith Center for Infectious Disease Research
Michael W. Konstan
Michael W. Konstan Case Western Reserve University
David P. Speert
David P. Speert University of British Columbia
Robert K. Ernst
Robert K. Ernst University of Maryland, Baltimore
John P. Clancy
John P. Clancy Cystic Fibrosis Foundation

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying microbiology in the USA opens up various career opportunities in healthcare, research, and biotechnology. For those exploring healthcare roles, understanding pathways such as becoming a functional medicine nurse practitioner can complement a microbiology background by integrating patient care with holistic health approaches.

Online degrees also provide flexible options for many students, including those with unique challenges. For example, the best associate degrees for felons highlight accessible educational routes that can lead to stable careers, emphasizing inclusivity within education and employment.

Another growing field linked to microbiology is medical coding. Earning a professional coder certification equips individuals with skills to manage healthcare data, a vital aspect of medical research and administration.

For those interested in specialized healthcare roles, understanding compensation is important. Insights into how much does a child life specialist make can guide decisions about related careers focused on patient support and wellbeing.

Best Scientists Citing Jane L. Burns

Trending Scientists

Recently Published Articles